Literature DB >> 8204562

Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.

G Faludi1, K Tekes, L Tóthfalusi.   

Abstract

High affinity 3H-paroxetine and 3H-imipramine binding sites were simultaneously studied in platelets of 29 untreated patients with panic disorder and 12 healthy controls. The maximum number of binding sites (Bmax) was found to be significantly lower in the panic patients compared to the controls using either ligand. No difference in the Kd values between the groups of subjects was found. The disturbance of serotonin neurotransmission in panic disorder--decrease in Bmax values--may be either a consequence or a reason of serotonergic dysfunction.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8204562      PMCID: PMC1188574     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  29 in total

1.  Chlorimipramine--but not imipramine--rapidly reduces imipramine--but not paroxetine--binding in human platelets.

Authors:  P Plenge; E T Mellerup; O J Rafaelsen
Journal:  Clin Neuropharmacol       Date:  1986       Impact factor: 1.592

2.  High affinity [3H]imipramine binding and serotonin uptake to platelets of adolescent females suffering from anorexia nervosa.

Authors:  R Weizman; M Carmi; S Tyano; A Apter; M Rehavi
Journal:  Life Sci       Date:  1986-03-31       Impact factor: 5.037

3.  Differential 3H-imipramine platelet binding in patients with panic disorder and depression.

Authors:  R B Innis; D S Charney; G R Heninger
Journal:  Psychiatry Res       Date:  1987-05       Impact factor: 3.222

4.  High-affinity imipramine binding and serotonin uptake in platelets of eight adolescent and ten adult obsessive-compulsive patients.

Authors:  A Weizman; M Carmi; H Hermesh; A Shahar; A Apter; S Tyano; M Rehavi
Journal:  Am J Psychiatry       Date:  1986-03       Impact factor: 18.112

5.  Platelet [3H]imipramine binding in patients with panic disorder.

Authors:  T W Uhde; W H Berrettini; P P Roy-Byrne; J P Boulenger; R M Post
Journal:  Biol Psychiatry       Date:  1987-01       Impact factor: 13.382

6.  Quantitative autoradiography of [3H]indalpine binding sites in the rat brain: I. Pharmacological characterization.

Authors:  J Bénavidès; H E Savaki; C Malgouris; C Laplace; C Margelidon; M Daniel; J Courteix; A Uzan; C Guérémy; G Le Fur
Journal:  J Neurochem       Date:  1985-08       Impact factor: 5.372

7.  Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen.

Authors:  R Raisman; R Cash; Y Agid
Journal:  Neurology       Date:  1986-04       Impact factor: 9.910

8.  Tritiated imipramine binding to platelets is decreased in patients with agoraphobia.

Authors:  D A Lewis; R Noyes; W Coryell; J Clancy
Journal:  Psychiatry Res       Date:  1985-09       Impact factor: 3.222

9.  High affinity binding of 3H-paroxetine and 3H-imipramine to rat neuronal membranes.

Authors:  E T Mellerup; P Plenge
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

10.  Temperature dependence of drug interaction with the platelet 5-hydroxytryptamine transporter: a clue to the imipramine selectivity paradox.

Authors:  A Segonzac; H Schoemaker; S Z Langer
Journal:  J Neurochem       Date:  1987-02       Impact factor: 5.372

View more
  1 in total

Review 1.  Panic disorder. Pathophysiology and drug treatment.

Authors:  M R Johnson; R B Lydiard; J C Ballenger
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.